Frank Buttgereit, M.D., has received consultancy fees, honoraria and travel expenses from Merck Serono, Horizon Pharma (formerly Nitec
Pharma), Mundipharma International Ltd., and grant support from Merck Serono and Horizon Pharma.
Reddy's, Biosense, Avanir, Cerimon, Leerink Swann, Alimera, Nomura, Luxor, Paraexel, Nitec
, Bayer Pharmaceuticals, Cominatoryx, Rigel Pharmacuticals, Chelsea, Regeneron Pharmaceuticals, Genelabs, Cypress, SNBL, Solace, Puretechventures, Puretech Development, White Mountain Pharma, TAP Pharmaceuticals, Abbott Laboratories, Cell Therapeutics, Omeros, Jazz Pharmaceuticals, Shwarz Pharma, Proethic, Takeda Pharmaceuticals, Teva Pharmaceuticals, Zydus, Proprius, Savient, Alder, Cure, Cellegy, Chemocentryx, McKesson, Diobex, Sepracor, Purdue Pharma, Serono, Coley, MedImmune, Altea, Neuromed, Polymerix, Talagen and Tigenix.
Determined to pursue a university degree, he took the unconventional academic route of first graduating with a Higher NITEC
in Business IT from the Institute of Technical Education and obtaining a Diploma in Industrial and Operations Management from Republic Polytechnic, before pursuing his undergraduate studies at NTU.